10 neuroscience biotech companies you should know about
WEBAug 15, 2024 · Developing treatments for neurological diseases presents a huge challenge for neuroscience companies within the biotech industry. The central nervous system (CNS) is extremely complex and many neurological diseases can be difficult to treat due to the limited regenerative capacity of the CNS, and the fact that the blood-brain barrier – a specialized system of cells that blocks harmful ...
Labiotech.eu - Europe's leading Biotech News Website
WEB3 days ago · ADCs that deliver: The secret lies in rigorous characterization. Explore the challenges of ADC characterization, key techniques, and the benefits of partnering with a CDMO for effective development. Labiotech.eu covers the global biotech industry, read by 150,000+ monthly visitors. Hope you'll enjoy our Biotech News!
Needle-free diabetes care: 7 devices that painlessly monitor blood …
WEBOct 7, 2022 · D-Base is a shoebox-sized blood sugar monitor developed by the German firm DiaMonTech. The device measures blood sugar levels by beaming an infrared laser through the skin of a finger and causing glucose in the skin to convert the light to heat. The machine then calculates glucose levels based on the increase of heat in the skin.
The twelve hottest biotech companies in the Boston area
WEBMar 12, 2024 · The Boston region has sprouted many influential public biotech companies. One of the most successful in recent years was Moderna, a giant messenger RNA (mRNA) specialist incubated by the VC firm Flagship Pioneering. Moderna would go on to produce one of the first COVID-19 vaccines in 2020. Another prestigious name, Vertex Pharmaceuticals, one ...
What trends will shape the biotech industry in 2024?
WEBJan 25, 2024 · Experts in the field believe that the biotech industry is poised for recovery in 2024, and one reason for that would be a favorable climate for M&A activity. A PwC report predicts the M&A deal totals could range from $225 billion to $275 billion. M&A will be among the trends that will influence the biotech market in 2024.
Five AI drug discovery companies you should know about
WEBJan 5, 2024 · In November 2023, Cradle raised $24 million in series A financing led by Index Ventures with participation from Kindred Capital. This funding round took the total raised by the AI drug discovery company to date to $33 million. Exscientia . Considered a pioneer in the field of AI within the biopharma industry, Exscientia is an AI-driven precision medicine company committed to discovering ...
This Bulletproof Skin is Made of Goat Milk Spider Silk - Labiotech.eu
WEBJul 30, 2018 · 3 minutes. Jalila Essaïdi is a Dutch artist and entrepreneur focused on biotech applications of spider silk, which she makes using the milk of genetically engineered goats. Spider silk is one of the strongest materials in nature. Jalila Essaïdi had her curiosity piqued when she read about the work of Randolph Lewis, a Professor at Utah State ...
18 biotech companies in Switzerland to keep an eye on in 2024
WEBJul 2, 2024 · ALE.C04 is the Swiss biotech’s lead candidate in oncology. This monoclonal antibody targets CLDN1+ tumors and is currently in a phase 1/2 clinical trial for head and neck squamous cell carcinoma (HNSCC). It is being tested both as a monotherapy and in combination with pembrolizumab, an anti-PD-1 antibody.
15 biotech companies shaking up the scene in Cambridge
WEBOct 6, 2022 · Founded: 2012. Cambridge Epigenetix was founded by Cambridge professor Sir Shankar Balasubramanian, who co-invented the technology behind next-generation sequencing now used by DNA sequencing giant Illumina. Cambridge Epigenetix pioneered epigenetic tests for the early detection of cancer and other diseases.
Seven diseases CRISPR technology could cure - Labiotech.eu
WEBApril 4, 2024 - Updated on May 6, 2024. 11 minutes. CRISPR technology offers the promise to cure human genetic diseases with gene editing. This promise became a reality when the world’s first CRISPR therapy was approved by regulators to treat patients with sickle cell disease and beta-thalassemia last year.